Recent Setbacks in Measles Elimination: The Importance of Investing in Innovations for Immunizations

Pan Afr Med J. 2020 Feb 20;35(Suppl 1):15. doi: 10.11604/pamj.supp.2020.35.1.21740. eCollection 2020.

Abstract

The recent setbacks in efforts to achieve measles elimination goals are alarming. To reverse the current trends, it is imperative that the global health community urgently intensify efforts and make resource commitments to implement evidence-based elimination strategies fully, including supporting research and innovations. The Immunization Agenda 2030: A Global Strategy to Leave No One Behind (IA2030) is the new global guidance document that builds on lessons learned and progress made toward the GVAP goals, includes research and innovation as a core strategic priority, and identifies measles as a "tracer" for improving immunisation services and strengthening primary health care systems. To achieve vaccination coverage and equity targets that leave no one behind, and accelerate progress toward disease eradication and elimination goals, sustained and predictable investments are needed for the identified research and innovations priorities for the new decade.

Keywords: Measles elimination; immunizations; investing in innovations.

Publication types

  • Editorial